Novel risk markers for gastric cancer screening: Present status and future prospects

doi:10.4253/wjge.v2.i12.381

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4741)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

456

HTML

3779

Figures (1-5)

285

Tables (1-1)

221

Sum=4741

Dec 16, 2010 (publication date) through Dec 11, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Endosc. Dec 16, 2010; 2(12): 381-387
Published online Dec 16, 2010. doi: 10.4253/wjge.v2.i12.381

Full Size Figure Download Figure

Figure 1 Kaplan-Meier analysis of gastric cancer development in subjects classified using the index of the pepsinogen test (modified from Yanaoka et al[25]). This shows the annual incidence of gastric cancer (GC) in each population identified based on serum pepsinogen test index criteria in middle-aged healthy men. With chronic atrophic gastritis progression, incidence of GC increased in a stepwise and significant manner. PG: pepsinogen.

Citation: Enomoto S, Maekita T, Ohata H, Yanaoka K, Oka M, Ichinose M. Novel risk markers for gastric cancer screening: Present status and future prospects. World J Gastrointest Endosc 2010; 2(12): 381-387
URL: https://www.wjgnet.com/1948-5190/full/v2/i12/381.htm
DOI: https://dx.doi.org/10.4253/wjge.v2.i12.381